Compounding Pharmacies Market: By Product Type, By Therapeutic Area, By Application, By Distribution Channel, and Region Forecast 2019-2030

Compounding Pharmacies Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Oral, Topical, Mouthwashes, Suppositories), By Therapeutic Area (Hormone Replacement Therapy, Pain Medications, Dermatological Conditions, Others), By Application (Children Drugs, Adult Drugs, Geriatric Drugs, Veterinary Drugs), By Distribution Channel (Traditional Stores, Compounding Pharmacies), and Region Forecast 2019-2030

Compounding Pharmacies Market size was valued at US$ 9.4 billion in 2023 and is poised to grow at a CAGR of 6.2.% from 2024-2030. Moreover, the convenience with the compounded medicines such as required dose for patients and convenient dosage form is anticipated to upsurge the revenue of compounded pharmacies market. Similarly, availability of compounding medicines in wide therapeutic areas, rise in awareness among healthcare professionals, and compounding of multi-component drugs also expected to boost the compound pharmacies market. Furthermore, acquisitions, mergers, and collaborations between the players of the market oxy-fuel combustion technology the revenue of compounded pharmacies market growth.

The market combine and prepare the personalized medicine by a licensed pharmacist or under guidance of physicians. These medicines are compounded by altering, mixing, or combining the active pharmaceutical ingredients with suitable additives in appropriate concentrations. These drugs can be prepared with or without prescriptions. However, these drugs are not approved by regulatory agencies and do not verify the effectiveness and safety of drugs. Compounded drugs are not covered by reimbursement schemes or any other pharmaceutical benefit agencies. The ageing population and improved life expectancy are offering significant market growth potential. Compounding pharmacies will also be in high demand because to the rising rate of drug failure and the global drug scarcity. Furthermore, higher acceptance of compounded medications will be pushed by increased understanding of the benefits of compounded medications.

Compounding Pharmacies Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.2%

Largest Market

North America

Fastest Growing Market

Europe

Compounding Pharmacies Market Dynamics

Patent expiration of various blockbuster drugs, increase in demand for the regenerative compounded medicines, availability of compounded drugs in multi-ingredient combinations for various therapeutic areas such as hormone replacement therapy and dermatology, and various advantages with compounded medicines such as dosage according to patient need are anticipated to fuel the compounded pharmacies market. Moreover, high cost of branded prescription drugs, rise in medicinal droughts of the prescription medicine, and availability in alternate dosage forms such as lozenges and liquids to overcome the drug administration difficulties are expected to boost the market. However, the lack of skilled staff, adverse effects associated with improperly compounded medications, and high cost of maintenance for sterile area and equipment are expected to impede the growth of the market.

Compounding Pharmacies Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 9.4 billion

Market CAGR

6.2%

By Product Type

  • Oral
  • Topical
  • Mouthwashes
  • Suppositories

By Therapeutic Area

  • Hormone Replacement Therapy
  • Pain Medications
  • Dermatological Conditions
  • Others

By Application

  • Children Drugs
  • Adult Drugs
  • Geriatric Drugs
  • Veterinary Drugs

By Distribution Channel

  • Traditional Stores
  • Compounding Pharmacies

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The compounding pharmacies market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The global compounding pharmacies market size was valued at US$ 9.4 billion in 2023 and is projected to grow at a CAGR of 6.2% from 2024 to 2030.

Shortage of Drugs and Rising Geriatric Population

Europe is the fastest-growing for the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Compounding Pharmacies Market Introduction 
2.1.Global Compounding Pharmacies Market  - Taxonomy
2.2.Global Compounding Pharmacies Market  - Definitions
2.2.1.Product Type
2.2.2.Therapeutic Area
2.2.3.Application
2.2.4.Distribution Channel
2.2.5.Region
3.Global Compounding Pharmacies Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Compounding Pharmacies Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Compounding Pharmacies Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Oral
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Topical
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Mouthwashes
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Suppositories
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Compounding Pharmacies Market  By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hormone Replacement Therapy
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Pain Medications
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Dermatological Conditions
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Compounding Pharmacies Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Children Drugs
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Adult Drugs
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Geriatric Drugs
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Veterinary Drugs
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Compounding Pharmacies Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Traditional Stores
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Compounding Pharmacies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9.Global Compounding Pharmacies Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Compounding Pharmacies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Oral
10.1.2.Topical
10.1.3.Mouthwashes
10.1.4.Suppositories
10.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hormone Replacement Therapy
10.2.2.Pain Medications
10.2.3.Dermatological Conditions
10.2.4.Others
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Children Drugs
10.3.2.Adult Drugs
10.3.3.Geriatric Drugs
10.3.4.Veterinary Drugs
10.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Traditional Stores
10.4.2.Compounding Pharmacies
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Compounding Pharmacies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Oral
11.1.2.Topical
11.1.3.Mouthwashes
11.1.4.Suppositories
11.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hormone Replacement Therapy
11.2.2.Pain Medications
11.2.3.Dermatological Conditions
11.2.4.Others
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Children Drugs
11.3.2.Adult Drugs
11.3.3.Geriatric Drugs
11.3.4.Veterinary Drugs
11.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Traditional Stores
11.4.2.Compounding Pharmacies
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Compounding Pharmacies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Oral
12.1.2.Topical
12.1.3.Mouthwashes
12.1.4.Suppositories
12.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hormone Replacement Therapy
12.2.2.Pain Medications
12.2.3.Dermatological Conditions
12.2.4.Others
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Children Drugs
12.3.2.Adult Drugs
12.3.3.Geriatric Drugs
12.3.4.Veterinary Drugs
12.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Traditional Stores
12.4.2.Compounding Pharmacies
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Compounding Pharmacies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Oral
13.1.2.Topical
13.1.3.Mouthwashes
13.1.4.Suppositories
13.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Hormone Replacement Therapy
13.2.2.Pain Medications
13.2.3.Dermatological Conditions
13.2.4.Others
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Children Drugs
13.3.2.Adult Drugs
13.3.3.Geriatric Drugs
13.3.4.Veterinary Drugs
13.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Traditional Stores
13.4.2.Compounding Pharmacies
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Compounding Pharmacies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Oral
14.1.2.Topical
14.1.3.Mouthwashes
14.1.4.Suppositories
14.2.  Therapeutic Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Hormone Replacement Therapy
14.2.2.Pain Medications
14.2.3.Dermatological Conditions
14.2.4.Others
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Children Drugs
14.3.2.Adult Drugs
14.3.3.Geriatric Drugs
14.3.4.Veterinary Drugs
14.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Traditional Stores
14.4.2.Compounding Pharmacies
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Braun Melsungen AG (Germany)
15.2.2.Institutional Pharmacy Solutions, LLC (U.S.)
15.2.3.Fresenius Kabi AG (Germany)
15.2.4.PharMEDium Services, LLC (U.S.)
15.2.5.Fagron (Belgium)
15.2.6.Cantrell Drug Company (U.S.)
15.2.7.Pencol Compounding Pharmacy (U.S.)
15.2.8.Imprimis Pharmaceuticals, Inc. (U.S.)
15.2.9.Panaceutics, Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Braun Melsungen AG (Germany)
  • Institutional Pharmacy Solutions, LLC (U.S.)
  • Fresenius Kabi AG (Germany)
  • PharMEDium Services, LLC (U.S.)
  • Fagron (Belgium)
  • Cantrell Drug Company (U.S.)
  • Pencol Compounding Pharmacy (U.S.)
  • Imprimis Pharmaceuticals, Inc. (U.S.)
  • Panaceutics, Inc. (U.S.)

Related Industry Reports